Insight ALK Resistance
Insight ALK Resistance™ offers clinicians reliable information about the mutational status of ALK in real time so they can best determine future treatment plans. This assay is critical because patients frequently develop ALK-inhibitor resistance mutations while under treatment with a targeted therapy. Insight ALK Resistance can identify the most clinically relevant inhibitor-resistance mutations and help guide treatment choices for patients who experience recurrence of their disease. Learn more about resistance mutations.
For more information on the application of Insight ALK Screen and Insight ALK Resistance as companion diagnostics, please contact us. To learn more about our ALK reference testing, please visit Insight Molecular Labs.